HIGHLIGHTS
- who: Udo Bavendiek from the (UNIVERSITY) have published the article: Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial, in the Journal: (JOURNAL)
- what: This study aimed to develop a simple dosing score when starting the cardiac glycoside digitoxin in heart failure with reduced ejection fraction (HFrEF) employing first data from the randomized double-blinded DIGIT-HF trial. Analysis, a score was developed, which can easily be used in clinical practice to select initial digitoxin dosing to avoid overdosing. Since age was kept in the model for clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.